Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 21/5/2019
SIETES contiene 92751 citas

 1 a 20 de 31 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Sultana J, Moretti U, Addis A, Caduff P, Capuano A, Kant A, Laporte J-R, Lindquist M, Raine J, Sartori D, Trifirò G, Tuccori M, Venegoni M, van Puijenbroek E, Leone R. Workshop on the Italian pharmacovigilance system in the international context: critical issues and perspectives. Drug Saf 2019;42:mayo. [Ref.ID 103115]
Edwards IR, Lindquist M. Social media and networks in pharmacovigilance: boon or bane?. Drug Saf 2011;34:267-71. [Ref.ID 90433]
3. Cita con resumen
Caster O, Edwards IR, Norén GN, Lindquist M. Earlier discovery of pregabalin's dependence potential might have been possible. Eur J Clin Pharmacol 2011;67:319-20. [Ref.ID 90103]
4. Cita con resumen
Derijks H, Meyboom RHB, Heerdink ER, De Koning FHP, Janknegt R, Lindquist M, Egberts ACG. The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. Eur J Clin Pharmacol 2008;64:531-8. [Ref.ID 82990]
Lindquist M. The need for definitions in pharmacovigilance. Drug Saf 2007;30:825-30. [Ref.ID 81223]
Stahl M, Lindquist M, Edwards IR, Brown EG. Introducing triage logic as a new strategy for the detection of signals in the WHO Drug Monitoring Database. Pharmacoepidemiol Drug Saf 2004;13:355-63. [Ref.ID 70402]
7.Tiene citas relacionadas
Bate A, Edwards RI, Lindquist M, Orre R. Violation of homogeneity: a methodologic issue in the use of data mining tools. The authors' reply. Drug Saf 2003;26:364-6. [Ref.ID 65881]
Bate A, Lindquist M, Orre R, Edwards LR, Meyoboom RHB. Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs. Eur J Clin Pharmacol 2002;58:483-90. [Ref.ID 63693]
Bate A, Lindquist M, Edwards IR, Orre R. A data mining approach for signal detection and analysis. Drug Saf 2002;25:393-7. [Ref.ID 62245]
11. Cita con resumen
van Puijenbroek EP, Bate A, Leufkens HGM, Lindquist M, Orre R, Egberts ACG. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 2002;11:3-10. [Ref.ID 61313]
12. Cita con resumen
Coulter DM, Bate A, Meyboom RHB, Lindquist M, Edwards IR. Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study. BMJ 2001;322:1207-9. [Ref.ID 56538]
Lindquist M, Stahl M, Bate A, Edwards IR, Meyboom RHB. A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO International Database. Drug Saf 2000;23:533-42. [Ref.ID 54161]
14. Cita con resumen
Meyboom RHB, Lindquist M, Flygare AK, Biriell C, Edwards IR. The value of reporting therapeutic ineffectiveness as an adverse drug reaction. Drug Saf 2000;23:95-9. [Ref.ID 51906]
15. Cita con resumen
Meyboom RHB, Lindquist M, Egberts ACG. An ABC of drug-related problems. Drug Saf 2000;22:415-23. [Ref.ID 51340]
Farah MH, Edwards R, Lindquist M, Leon C, Shaw D. International monitoring of adverse health effects associated with herbal medicines. Pharmacoepidemiol Drug Saf 2000;9:105-12. [Ref.ID 50426]
Lindquist M, Edwards IR, Bate A, Fucik H, Nunes A M. From association to alert - a revised approach to international signal analysis. Pharmacoepidemiol Drug Saf 1999;8:15-25. [Ref.ID 44324]
Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, De Freitas RM. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 1998;54:315-21. [Ref.ID 39267]
Lindquist M, Pettersson M, Edwards IR, Sanderson J, Taylor N, Fletcher P, Schou J, Fraunfelder FT. How does cystitis affect a comparative risk profile of tiaprofenic acid with other non-steroidal antiinflammatory drugs? An international study based on spontaneous reports and drug usage data. Pharmacol Toxicol 1997;80:211-7. [Ref.ID 38008]
Stahl MMS, Lindquist M, Pettersson M, Edwards IR, Sanderson JH, Taylor NFA, Fletcher AP, Schou JS. Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system. Eur J Clin Pharmacol 1997;53:163-9. [Ref.ID 36583]
Seleccionar todas
 1 a 20 de 31 siguiente >>